Sam S. Chang MD, MBA Profile
Sam S. Chang MD, MBA

@UroCancerMD

Followers
4K
Following
15K
Media
81
Statuses
1K

Patricia and Rodes Hart Endowed Chair, Chief Surgical Officer, Vanderbilt Ingram Cancer Center

Nashville, TN
Joined August 2011
Don't wanna be here? Send us removal request.
@UroCancerMD
Sam S. Chang MD, MBA
28 days
RT @DDJoyce_BFA: TMT for MIBC is a crucial treatment option for our patients. šŸ’µHowever, its current costs are u….
0
10
0
@UroCancerMD
Sam S. Chang MD, MBA
1 month
RT @urotoday: Real-world experience with nadofaragene firadenovec treatment for BCG-unresponsive #BladderCancer. @MarkTysonMD @MayoClinic &….
0
3
0
@UroCancerMD
Sam S. Chang MD, MBA
1 month
RT @urotoday: #SunRISe1 trial shows #TAR200 efficacy in BCG-unresponsive #BladderCancer. @DrFelixGuerrero sits down with @UroCancerMD @VUMC….
0
8
0
@UroCancerMD
Sam S. Chang MD, MBA
1 month
RT @urotoday: #CISTO study: Comparing cystectomy vs. bladder-sparing therapy for recurrent #NMIBC. John Gore, MD, MS @fredhutch joins @UroC….
0
4
0
@UroCancerMD
Sam S. Chang MD, MBA
1 month
RT @allaf_mo: Delighted to announce Noah Hahn & Max Kates @MaxKates new CoDirectors of Greenberg Bladder Cancer Institute @brady_urology Gr….
0
9
0
@UroCancerMD
Sam S. Chang MD, MBA
1 month
RT @Uromigos: @JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the….
0
29
0
@UroCancerMD
Sam S. Chang MD, MBA
1 month
Congrats and so well-deserved! .@MaxKates.
@allaf_mo
Mohamad Allaf
1 month
Congratulations Max Kates @MaxKates The R. Christian B. Evensen Professor in Urology, one of the highest honors in academic medicine. A superstar surgeon-scientist, teacher, and all around amazing person. @bradyurology @HopkinsMedicine
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
0
11
@UroCancerMD
Sam S. Chang MD, MBA
1 month
RT @allaf_mo: Congratulations Max Kates @MaxKates The R. Christian B. Evensen Professor in Urology, one of the highest honors in academic m….
0
12
0
@UroCancerMD
Sam S. Chang MD, MBA
2 months
RT @urotoday: Circulating and urinary tumor DNA in #BladderCancer treatment and surveillance. @alantanmd joins @UroCancerMD to discuss how….
0
3
0
@UroCancerMD
Sam S. Chang MD, MBA
2 months
RT @MarkTysonMD: BCG > gem for LG IR-NMIBC (better RFS); RARC = ORC (RAZOR: no diff in major comps/readmits —>frailty is the key); bilatera….
Tweet card summary image
auajournals.org
0
10
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @urotoday: Perioperative systemic therapies for muscle-invasive #BladderCancer. Jacqueline Brown, MD @WinshipAtEmory joins @UroCancerMD….
0
2
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @urotoday: #BOND003 Cohort P results for BCG-unresponsive papillary bladder tumors. @MarkTysonMD @MayoClinic joins @UroCancerMD @VUMCuro….
0
2
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @rwjurology: All šŸ’« @RutgersCancer urologic oncology team @saumyg @VigneshPackiam @DGolombos @TomJangUroOncšŸ‘‡šŸ¼Impactful work aimed to impr….
0
6
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @katy_beckermann: Excited to join the World GU Conference, always a great way to hear expert insights and apply data to everyday care. E….
0
2
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @UroOnc: Thank you to all who came out to the SUO at AUA meeting in Vegas! Great meeting with so much information. We are now preparing….
0
2
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @urotoday: Highlights from #SUO24!.@AmyLuckenbaugh @VUMChealth & @UroCancerMD @VUMCurology dive into late-breaking #bladdercancer trials….
0
3
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @alantanmd: Thanks @urotoday grateful to work w @UroCancerMD, future is bright for patients as we incorporate highly effective ADC/IO co….
0
4
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @JoshMeeks: Speechless QOL better after cystectomy #AUA2025
Tweet media one
0
23
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @KKseattle: Congratulations to my dear friend, ⁦@AnnGormley1⁩, for her well deserved receipt of the prestigious Victor Politano award !….
0
6
0
@UroCancerMD
Sam S. Chang MD, MBA
3 months
RT @Uromigos: Neal Shore joins us to discuss the CREST trial of sasanlimab +/- BCG in high-risk NMIBC from the @AmerUrological 2025 Annual….
0
13
0